283 related articles for article (PubMed ID: 26911732)
1. Treatment of Metastatic Lymph Nodes in the Neck from Papillary Thyroid Carcinoma with Percutaneous Laser Ablation.
Mauri G; Cova L; Ierace T; Baroli A; Di Mauro E; Pacella CM; Goldberg SN; Solbiati L
Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1023-30. PubMed ID: 26911732
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous laser ablation of metastatic lymph nodes in the neck from papillary thyroid carcinoma: preliminary results.
Mauri G; Cova L; Tondolo T; Ierace T; Baroli A; Di Mauro E; Pacella CM; Goldberg SN; Solbiati L
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1203-7. PubMed ID: 23666969
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer.
Papini E; Bizzarri G; Bianchini A; Valle D; Misischi I; Guglielmi R; Salvatori M; Solbiati L; Crescenzi A; Pacella CM; Gharib H
J Clin Endocrinol Metab; 2013 Jan; 98(1):E92-7. PubMed ID: 23150695
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma.
Guang Y; Luo Y; Zhang Y; Zhang M; Li N; Zhang Y; Tang J
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1555-1562. PubMed ID: 28342000
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma.
Lewis BD; Hay ID; Charboneau JW; McIver B; Reading CC; Goellner JR
AJR Am J Roentgenol; 2002 Mar; 178(3):699-704. PubMed ID: 11856701
[TBL] [Abstract][Full Text] [Related]
6. Role of ultrasound in the assessment of percutaneous laser ablation of cervical metastatic lymph nodes from thyroid carcinoma.
Zhang L; Zhou W; Zhan W
Acta Radiol; 2018 Apr; 59(4):434-440. PubMed ID: 28786300
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-guided Radiofrequency Ablation for Cervical Lymph Nodes Metastasis from Papillary Thyroid Carcinoma.
Guang Y; Luo YK; Zhang Y; Zhang MB; Li N; Zhang Y; Tang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Feb; 40(1):67-71. PubMed ID: 29532783
[TBL] [Abstract][Full Text] [Related]
9. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
10. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma.
Wang L; Ge M; Xu D; Chen L; Qian C; Shi K; Liu J; Chen Y
J Cancer Res Ther; 2014 Nov; 10 Suppl():C144-9. PubMed ID: 25450273
[TBL] [Abstract][Full Text] [Related]
12. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
Wu X; Gu H; Gao Y; Li B; Fan R
Nucl Med Commun; 2018 Jan; 39(1):22-27. PubMed ID: 29135721
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma.
Heilo A; Sigstad E; Fagerlid KH; Håskjold OI; Grøholt KK; Berner A; Bjøro T; Jørgensen LH
J Clin Endocrinol Metab; 2011 Sep; 96(9):2750-5. PubMed ID: 21715533
[TBL] [Abstract][Full Text] [Related]
15. Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated Thyroid Cancer.
Miller JE; Al-Attar NC; Brown OH; Shaughness GG; Rosculet NP; Avram AM; Hughes DT
Thyroid; 2018 May; 28(5):593-600. PubMed ID: 29562827
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous laser ablation of cervical metastatic lymph nodes in papillary thyroid carcinoma: clinical efficacy and anatomical considerations.
Spartalis E; Karagiannis SP; Plakopitis N; Theodori MA; Athanasiadis DI; Schizas D; Spartalis M; Troupis T
Expert Rev Med Devices; 2021 Jan; 18(1):75-82. PubMed ID: 33307870
[No Abstract] [Full Text] [Related]
17. Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer.
Yoo D; Ajmal S; Gowda S; Machan J; Monchik J; Mazzaglia P
World J Surg; 2012 Jun; 36(6):1255-61. PubMed ID: 22430670
[TBL] [Abstract][Full Text] [Related]
18. Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up.
Carcoforo P; Portinari M; Feggi L; Panareo S; De Troia A; Zatelli MC; Trasforini G; Degli Uberti E; Forini E; Feo CV
Surgery; 2014 Jul; 156(1):147-57. PubMed ID: 24929764
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.
Conzo G; Mauriello C; Docimo G; Gambardella C; Thomas G; Cavallo F; Tartaglia E; Napolitano S; Varriale R; Rossetti G; Fei L; Santini L
Int J Surg; 2014; 12 Suppl 1():S194-7. PubMed ID: 24862675
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected "recurrent" neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy.
Hay ID; Lee RA; Davidge-Pitts C; Reading CC; Charboneau JW
Surgery; 2013 Dec; 154(6):1448-54; discussion 1454-5. PubMed ID: 24176579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
